Latest Nanexa News & Updates

See the latest news and media coverage for Nanexa. We track all announcements, press releases, and industry mentions in real time, all in one place.

Nanexa

Pharmaceutical company developing long-acting injectable drug products

nanexa.com

Headquarters: Uppsala, Sweden
Founded year: 2007
Company type: Public company
Number of employees: 26–50
Industry: Medical Equipment, Supplies & Distribution

Last updated November 4

Latest news about Nanexa

In short: Nanexa signed a Novo Nordisk license deal worth up to €1.165 billion and advanced manufacturing.

Company announcements

November 4 Nanexa

Nanexa reports third-quarter 2026 operating profit of TSEK 157,332

Turnover amounts to TSEK 227,865 and profit after tax to TSEK 157,384, boosted by a EUR 1.165 billion Novo license agreement.

October 9 Nanexa

Nanexa secures €1.165 billion Novo Nordisk deal

Media outlets praised Nanexa's PharmaShell ALD technology for obesity and diabetes treatments.

September 24 Nanexa

Nanexa partners with Novo in EUR1.165b drug delivery deal

Novo gains exclusive global license for Nanexa's PharmaShell platform targeting obesity and diabetes.

August 27 Nanexa

Nanexa reports second quarter financial results for 2026

The company announces SEK 55.7 million from warrant exercises and a SEK 20 million share issuance via debt conversion alongside updated operational metrics.

Media coverage

October 28 Citeline

Nanexa’s Atomic Shell Game: How ALD Tech Landed A Novo Deal Worth Up To €1.165bn

Nanexa’s CEO said PharmaShell’s ALD-coated particles could stretch GLP-1 dosing to monthly or quarterly, but its semaglutide ...

September 24 Bloomberg

Novo Signs Delivery Deal With Nanexa Worth Up to $1.3 Billion

Novo Nordisk A/S signed a deal worth as much as €1.165 billion ($1.3 billion) with Sweden's Nanexa AB for rights to its drug delivery technology...

September 21 Zone Bourse

Nanexa and Novo conclude a $1.165 billion global license and collaboration agreement for long-acting injectables

Nanexa AB has announced that it has concluded an exclusive worldwide license and collaboration agreement with Novo Nordisk for the use of the PharmaShell technology platform...

December 10, 2025 FierceBiotech

Moderna taps Nanexa to improve delivery of injectable therapies in back-loaded $500M pact

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see...

Never miss news about Nanexa

Track Nanexa and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Nanexa competitors & trending companies

Browse news for competitors to Nanexa and other trending companies.